Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Cited by (351)

Items 301–351 of 351

  1. LNP-mRNA vaccines: Revolutionizing preventive medicine
    Sambridhi Bhowmik, Sweta Kundu, Suparna Ghosh, Avik Acharya Chowdhury, Ankita Acharya · 2026 · Elsevier eBooks
  2. A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics
    Kukushkina-Zvezdova, Alisa A., Zherebtsova, Anna A., Telegina, Darya V., Skvortsov, Ivan A., Ivanov, Roman A., Reshetnikov, Vasiliy V. · 2026 · Journal of Translational Medicine
  3. Preliminary Immunogenicity Evaluation of an Immunoinformatics-Guided Multi-Epitope mRNA Vaccine Against Porcine Epidemic Diarrhea Virus
    Yiqing Liu, Huanhui Huang, Ya Chen · 2026 · Vaccines
  4. mRNA Lipid Nanoparticles for Cell Engineering in Vivo and in Vitro: Current Applications and Future Directions
    Lingyun Li, Menglan Wang, Xiuhan Ye, Zhiyan Liu, Yijing Duan, Xiaoming Chen, Yue Ouyang, Qibiao Wu, Mengjuan Sun, Tian Xie · 2026 · MedComm
  5. Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles
    Shrusti Tiwari, Mokshada Kumar, Shengjia Wu, Rutuja Kulkarni, Dhaval K. Shah · 2026 · The AAPS Journal
  6. Advances in mRNA Delivery and Clinical Applications
    Bo Hu, Abid Hussain, Qing Lin Liu, Yuhua Weng, Yuanyu Huang · 2022 · RNA technologies
  7. Oligonucleotides and mRNA Therapeutics
    Erik Oude Blenke, Raymond Michel Schiffelers, Enrico Mastrobattista · 2024 · Springer eBooks
  8. Just the messenger
    Amanda B. Keener · 2018 · Nature Medicine
  9. Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy.
    Ali Fallah, Hajar Estiri, Elizabeth Parrish · 2020 · PubMed
  10. pDNA and mRNA vaccines
    Kanwal Gill, Leanne Minall, Aslin Rodríguez Nassif · 2021 · Elsevier eBooks
  11. mRNA疗法的研究进展与挑战
    Jiayan Fu, Shuo Feng, Binhe Du, Haiyang Dong, Jinzhong Lin, Jin Yongfeng · 2021 · Scientia Sinica Vitae
  12. Nanotechnology: New frontiers in anti-HIV therapy
    Josef Jampílek, Katarína Kráľová · 2022 · Elsevier eBooks
  13. H uman Immunodeficiency Virus ( HIV )
    Anna María Geretti · 2017 · Wiley eBooks
  14. The use of modified mRNA encoding platelet-derived growth factor-BB as an innovation in periodontal regeneration
    Theeraphat Surisaeng, Chantrakorn Champaiboon, Sathit Pichyangkul · 2019
  15. Single-hit genome edition for expression of single-chain immunoglobulins by edited B cells
    Natsuko Ueda, Marine Cahen, Christophe Sirac · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  16. New vaccines on the horizon
    Nevena Arsenović-Ranin · 2019 · Arhiv za farmaciju
  17. Utilization of modified mRNA encoding bone morphogenetic protein-2 for periodontal regeneration: an in vitro study
    Promphakkon Kulthanaamondhita, Rangsini Mahanonda, Sathit Pichyangkul · 2019
  18. Designing Synthetic Dna Encoded Immunotherapeutics And Nanoparticle Vaccines For Enhanced Immunity-Mediated Protection
    Ziyang Xu · 2020 · ScholarlyCommons (University of Pennsylvania)
  19. Vakzine: Gut umhüllt zum Ziel
    Christian Ehrensberger · 2021 · Nachrichten aus der Chemie
  20. Faculty Opinions recommendation of Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus.
    Graham Pawelec · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  21. Application of nucleic acid-encoded antibodies in prevention and treatment of emerging viral infectious diseases
    Suo-Qun Zhao, Hang Chi, Cheng‐Feng Qin, Yong‐Qiang Deng · 2023 · Chinese Science Bulletin (Chinese Version)
  22. Harnessing Gradients for Self-Assembly of Peptide-Based Nanocapsules: A Pathway to Advanced Drug Delivery Systems
    H.P. Li, Xuliang Qian, Harini Mohanram et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. The Application of mRNA in Treating Cancer
    Yi Wang · 2023 · MedScien
  24. Identification of Messenger RNA Signatures in Age-Dependent Renal Impairment
    Katsunori Yanai, Shohei Kaneko, Akinori Aomatsu · 2023 · Diagnostics
  25. Nanotheronostics: Part II
    Sikandar Shaikh · 2024 · Springer eBooks
  26. mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons
    Gaurav Mishra, Sunny Rathee, Munish Garg, Umesh Kumar Patil · 2025 · Current Drug Delivery
  27. Maternal transfer of mRNA LNP-derived, pathogen-specific, monoclonal IgG to suckling mice
    Jennifer E. Doering, Yetunde Adewunmi, Cailin E. Deal, Obadiah J. Plante, Andrea Carfı́, Nicholas John Mantis · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Development Of mRNA Vaccines And Therapeutics Beyond Covid-19
    Anubhi Yadav, Akanksha Dwivedi, G. N. Darwhekar · 2025 · European journal of parenteral & pharmaceutical sciences
  29. Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral Strategy
    Lin Li, Xiuli Yan, Haoyang Wang, Hangyu Zhou, Yuyan Li, Jian Li, Rongrong Zhang, Lu Lv, Xing‐Yao Huang, Hao Du et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems
    Ana Clara Barbosa Antonelli, Lucas Silva Rodrigues, Maria Clara Moura Pinheiro, Sylvia Barbosa Pinhate, Marcelo M. Brígido, Andréa Queiróz Maranhão · 2025 · Advanced Therapeutics
  31. The research progress on the design and application of mRNA antibody technology
    Feixue Du, X.Z. Xiong, Hang Chi, Yongqiang Deng, Xiaodong Han · 2025 · Chinese Science Bulletin (Chinese Version)
  32. Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection
    Thornwit Chavalparit, Craig P. Barry, Helen Gunter, Marianne Gillard, Tim R. Mercer, Esteban Marcellin · 2025 · mAbs
  33. Therapeutic potential of exogenous mRNA encoding recombinant antibodies against viral pathogens
    Sergey A. Klotchenko, Marina A. Plotnikova · 2025 · Medical academic journal
  34. Status and outlook of mRNA therapeutics for viral diseases
    Qiuwei Pan, Wenshi Wang, Janssen Hl, Zifu Zhong · 2026 · EMBO Molecular Medicine
  35. Research progress in ionizable cationic lipids in mRNA delivery: from synthetic strategies to applications
    Xinwei Zhang, Yuqin Liao, Xuechuan Hong, Yuling Xiao, Xiaodong Zeng · 2026 · Science China Chemistry
  36. Traitement de l’hémophilie A à l’aide d’ARNm codant le facteur VIII et prévention de la réponse immunitaire dirigée contre le facteur VIII thérapeutique
    Jules Russick · 2018
  37. Optimisation de stratégies génétiques de remplacement de la nature des immunoglobulines produites par une cellule B
    Natsuko Ueda · 2022
  38. Multifunctional nanocomposites for precise control over drug delivery
    Valentina Andretto · 2022 · theses.fr (ABES)
  39. An RNA-to-RNA pipeline for rapid antiviral antibody development
    Edgar A. Hodge, Jacob F. Archer, Jacqueline S. Anderson, Nikole L. Warner, Jacque Tremblay, Thomas Klose, Stephanie Park, Troy C. Hinkley, Amit P. Khandhar, Richard Kuhn et al. · 2026 · Molecular Therapy
  40. mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model
    Ashwin N. Skelly, Chengcheng Fan, Jennifer R. Keeffe, Arya B. Ökten, Edem Gavor, Maddy L. Newby, Joel D. Allen, Edward F. Kreider, Wenge Ding, Rebecca A Osbaldeston et al. · 2026 · Proceedings of the National Academy of Sciences
  41. mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications
    Wei Xu, Jun Wang, Xueke Liu, Mei Lü, Z K Zhang, Li Li · 2026 · Frontiers in Microbiology
  42. A ubiquitinated E2-based mRNA vaccine confers complete protection against lethal challenge with classical swine fever virus
    Huanjie Zhai, Yuxuan Gao, Nian Wan, Yuxin Qu, Su Li, Lian‐Feng Li, Ting Zhao, Qinghe Hou, Yuan Sun, Hongxia Wu et al. · 2026 · Journal of Virology
  43. Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field
    Matthew J. Slarve, Christine Tkaczyk, Michael P. Doyle, Timothy J. Break, Alexander B. Smith, Galit Alter, Brian M Luna, Brad J. Spellberg, Antonio DiGiandomenico · 2026 · BioDrugs
  44. Two Classes of Protein Therapeutics: Why Dose–Response Architecture Defines the Boundary of mRNA Medicines
    Sarfaraz K. Niazi · 2026 · Pharmaceutics
  45. Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases
    Moslem Naderian, Elham Davoudi, Salar Hafez Ghoran, Sara Sadeghian, Kamran Goudarzi, Issa Sadeghian · 2026 · DNA and Cell Biology
  46. Redox-responsive nanomaterials for mRNA delivery: From rational design to therapeutic applications
    Meng Li, Yifan Wang, Jing Gao, Soohwan An, Zhongmin Tang, Wei Tao · 2026 · Advanced Drug Delivery Reviews
  47. From COVID-19 experience to future readiness: a systematic review of pseudovirus and replicon systems in antiviral innovation
    Nabila Khan, Rafidah Lani, Pouya Hassandarvish · 2026 · Future Virology
  48. Intradermal immunoengineering with mRNA
    Taylor M. Patino, David J. Peeler · 2026 · Nanomedicine
  49. Experimental evidence and consequences of biomolecular corona formation on inhaled mRNA lipid nanoparticles
    Mélina Guérin, Asia Saorin, Alberto Martinez‐Serra · 2026 · Health Nanotechnology
  50. LNP-CpG: deploy the self-adjuvant role of mRNA vaccines
    Ning Luan, Han Cao, Xiaolong Zhang, Fengmei Yang, Caixia Lu, Yang He, Qianqian Li, Yanwei Bi, Zhanlong He, Shengtao Fan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Engineered antibodies: the molecular workhorses of the immune system as therapeutics
    Aditi Singh, Sucharita Shadangi, Souptik Bag, Soumendra Rana · 2026 · Elsevier eBooks